SOX9 and breast carcinoma: SRY‐Box 9 (Sox9) is certified as the target gene of miR‐215‐5p; furthermore, the inhibition effects of miR‐215‐5p on breast cancer cell migration ability and invasiveness are phenocopied by Sox9 slicing.